01
Health Technologies
IVF, laboratory technologies, medical products, diagnostic systems, regulation and clinical network management.
OPERATOR · STRATEGIC ADVISOR · TECHNOLOGY TRANSFER
Experience that moves technology toward commercialization and data toward decision.
Özgür Murat Ceylan is an operator and strategic advisor working across health technologies, technology transfer, international business development and energy systems, with a focus on turning technical data, performance indicators and field signals into commercial, operational and financial decisions.
25+Years of field experience
5Countries of operation
360°Regulation · sales · market
Istanbul · Healthtech · Ventures
FOCUS AREAS
Work focused on international market entry and commercialization across health technologies, energy systems and technology transfer.
02
International Business Development
Distribution structures, partner management, channel setup and market-entry strategies across Türkiye, Europe, Russia and the CIS region.
03
Technology Transfer
Patent assessment, licensing, startup analysis, investment readiness and commercialization of research outputs.
04
Energy Data & Risk Systems
BESS monitoring, performance analytics, insurance data, risk modelling, energy efficiency and decision-support systems.
OPERATING PHILOSOPHY
Good ideas often slow down not because of technical weakness, but because market, regulation, trust, data, pricing and the right points of contact are not brought together.
01
Start with the real problem
The product claim, customer need and willingness to pay are tested on the same ground.
02
Then build the trust architecture
Regulation, references, data reliability, distribution and institutional narrative are designed together.
03
Scale comes last
Market entry starts with small but provable steps; growth is built on that evidence.
EXPERIENCE
Health technologies, international operations, technology transfer and the language of financial decision-making.
His 25+ year career has been shaped by public regulation, banking audit, global pharma finance, IVF operations, health technologies, international business development and technology transfer.
He managed distribution structures and market-entry processes in IVF technologies, laboratory systems, medical products and clinical network management across Türkiye, Europe, Russia and the CIS region.
He took part as a representative and operator in patent commercialization work connected with Max Planck Institute and INSERM, and worked on bringing research outputs to market, startup assessment and investment readiness.
Today, he is expanding his focus toward energy storage systems, operational data analytics, risk modelling, insurance data, energy efficiency and AI-supported decision systems.
1998–2000
Republic of Türkiye Ministry of Industry and Trade
Started his career in consumer protection, inspection and regulatory processes.
2000–2001
Osmanlı Bank
Worked in credit analysis, audit and financial risk assessment processes.
2002–2005
Merck Serono
Worked at Merck Serono, a global biopharma company, in Darmstadt-based international financial analysis and performance evaluation processes.
2005–2009
Bahçeci Health Group — CFO
Contributed to IVF center setup, financial structuring and operational growth processes in Türkiye, the TRNC, Azerbaijan, Iraq and Kosovo.
2009–Bugün
Gonagen Medical Group — Managing Partner
Managed health technologies, genetics, IVF products, multi-country distribution structures, product registration, regulation and international business development processes.
Parallel
Max Planck Institute · INSERM
Took part in work related to patent commercialization, licensing, technology transfer and bringing scientific outputs to market.
Current
Go-to-Market, Mentoring & Energy Data
Works on commercialization, regulation, field implementation and investment readiness for early-stage ventures; and on BESS risks, prediction models, insurance data and AI-supported decision systems in the energy field.
Education
Ankara University Faculty of Political Sciences — Public Finance
An academic foundation strengthening his perspective on finance, public order, economic decision processes and regulation.
DURATION
25+ years
Health technologies, medical products, regulation, distribution, financial decision processes and international business development.
GEOGRAPHY
Türkiye · Europe · Russia · CIS
Partner, channel, trust, reference and product-positioning processes in multi-country markets.
TECHNOLOGY TRANSFER
Max Planck · INSERM
Representation and business development work related to the commercialization of research outputs and patents.
ENERGY DATA
Monitoring · Risk · Insurance
Connecting performance, risk and operational data to financial decision-making, insurance, maintenance and efficiency processes.
MENTORING & SEMINARS
Field-based knowledge transfer for founders, technology teams and institutions.
Mentoring and seminar work is a process of jointly assessing how a product connects to market, how data connects to decision, and how technology connects to a sustainable business model.
Early-Stage Venture Mentoring
Work with founders on product claim, real problem, market fit, regulation, first customer and investor narrative.
Technology Commercialization Sessions
Patent, research output, licensing and go-to-market assessments for universities, technoparks and research teams.
TALK & SEMINAR TOPICS
01
Moving technology toward commercialization and data toward decision
How research outputs, technical data and operational signals are converted into economic value.
TECHNOLOGY TRANSFER
02
AI is not a technology; it is a decision architecture
The role of data, processes, control systems and decision flows beyond the model in AI projects.
AI & DECISION SYSTEMS
03
Energy data, risk and insurance
The impact of monitoring, prediction and scoring systems on energy investments, BESS operations and the insurance ecosystem.
ENERGY SYSTEMS & RISK
04
Why does a health technology fail?
The fractures that occur when regulation, references, data reliability, clinical need and market-entry processes are not designed correctly.
HEALTH TECHNOLOGIES & REGULATION
WRITINGS & OBSERVATIONS
Notes, observations and field experience.
01
Observations on how Industry 4.0, maintenance systems, energy efficiency and performance data are translated into financial language.
02
The relationship between data architecture, validation and the real-world problem in healthcare AI and diagnostic projects.
03
The invisible tensions AI investments create in financial decision-making mechanisms.
04
Notes on why thinking in systems rather than models matters for control, process and structural design.
05
Personal observations on the strategic advantages, as well as the risks, of working across multiple sectors.
CONTACT
Let’s discuss the right market path for the right idea.
Introductory conversations can be scheduled around technology transfer, health technologies and energy data, including market entry, strategic positioning, risk analytics, insurance data, mentoring and seminar content.